244 related articles for article (PubMed ID: 38033725)
1. Unlocking the potential of platinum drugs: organelle-targeted small-molecule platinum complexes for improved anticancer performance.
Deng Z; Chen S; Liu G; Zhu G
RSC Chem Biol; 2023 Nov; 4(12):1003-1013. PubMed ID: 38033725
[TBL] [Abstract][Full Text] [Related]
2. An update on cell-penetrating peptides with intracellular organelle targeting.
Cerrato CP; Langel Ü
Expert Opin Drug Deliv; 2022 Feb; 19(2):133-146. PubMed ID: 35086398
[TBL] [Abstract][Full Text] [Related]
3. Monofunctional Platinum(II) Anticancer Agents.
Jin S; Guo Y; Guo Z; Wang X
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33562293
[TBL] [Abstract][Full Text] [Related]
4. Functionalization of Platinum Complexes for Biomedical Applications.
Wang X; Wang X; Guo Z
Acc Chem Res; 2015 Sep; 48(9):2622-31. PubMed ID: 26247558
[TBL] [Abstract][Full Text] [Related]
5. Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes.
Zhong Y; Jia C; Zhang X; Liao X; Yang B; Cong Y; Pu S; Gao C
Eur J Med Chem; 2020 May; 194():112229. PubMed ID: 32222677
[TBL] [Abstract][Full Text] [Related]
6. Recent Advances of Platinum-Based Anticancer Complexes in Combinational Multimodal Therapy.
Zhong T; Yu J; Pan Y; Zhang N; Qi Y; Huang Y
Adv Healthc Mater; 2023 Sep; 12(22):e2300253. PubMed ID: 37097737
[TBL] [Abstract][Full Text] [Related]
7. Research progress in modern structure of platinum complexes.
Bai L; Gao C; Liu Q; Yu C; Zhang Z; Cai L; Yang B; Qian Y; Yang J; Liao X
Eur J Med Chem; 2017 Nov; 140():349-382. PubMed ID: 28985575
[TBL] [Abstract][Full Text] [Related]
8. Blood Components as Carriers for Small-Molecule Platinum Anticancer Drugs.
Yao H; Zhu G
ChemMedChem; 2022 Dec; 17(23):e202200482. PubMed ID: 36178204
[TBL] [Abstract][Full Text] [Related]
9. Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
Alfonso-Triguero P; Lorenzo J; Candiota AP; Arús C; Ruiz-Molina D; Novio F
Nanomaterials (Basel); 2023 May; 13(10):. PubMed ID: 37242036
[TBL] [Abstract][Full Text] [Related]
10. Organelle Targeted Drug Delivery: Key Challenges, Recent Advancements and Therapeutic Implications.
Singh D
Endocr Metab Immune Disord Drug Targets; 2024 Jan; ():. PubMed ID: 38303531
[TBL] [Abstract][Full Text] [Related]
11. Photoactivatable Platinum-Based Anticancer Drugs: Mode of Photoactivation and Mechanism of Action.
Dai Z; Wang Z
Molecules; 2020 Nov; 25(21):. PubMed ID: 33171980
[TBL] [Abstract][Full Text] [Related]
12. Beyond platinums: gold complexes as anticancer agents.
Nardon C; Boscutti G; Fregona D
Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
[TBL] [Abstract][Full Text] [Related]
13. Novel Anticancer Platinum(IV) Complexes with Adamantylamine: Their Efficiency and Innovative Chemotherapy Strategies Modifying Lipid Metabolism.
Kozubík A; Vaculová A; Soucek K; Vondrácek J; Turánek J; Hofmanová J
Met Based Drugs; 2008; 2008():417897. PubMed ID: 18414587
[TBL] [Abstract][Full Text] [Related]
14. Organelle targeting: third level of drug targeting.
Sakhrani NM; Padh H
Drug Des Devel Ther; 2013; 7():585-99. PubMed ID: 23898223
[TBL] [Abstract][Full Text] [Related]
15. Recent Developments in the Field of Anticancer Platinum Complexes.
Galanski MS
Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):285-95. PubMed ID: 18221042
[TBL] [Abstract][Full Text] [Related]
16. Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches.
Galanski MS; Jakupec MA; Keppler BK
Curr Med Chem; 2005; 12(18):2075-94. PubMed ID: 16101495
[TBL] [Abstract][Full Text] [Related]
17. Future of nanotherapeutics: Targeting the cellular sub-organelles.
Ma X; Gong N; Zhong L; Sun J; Liang XJ
Biomaterials; 2016 Aug; 97():10-21. PubMed ID: 27155363
[TBL] [Abstract][Full Text] [Related]
18. Boosting Cancer Therapy with Organelle-Targeted Nanomaterials.
Gao P; Pan W; Li N; Tang B
ACS Appl Mater Interfaces; 2019 Jul; 11(30):26529-26558. PubMed ID: 31136142
[TBL] [Abstract][Full Text] [Related]
19. Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms.
Njenga LW; Mbugua SN; Odhiambo RA; Onani MO
Dalton Trans; 2023 May; 52(18):5823-5847. PubMed ID: 37021641
[TBL] [Abstract][Full Text] [Related]
20. Fresh platinum complexes with promising antitumor activity.
Wang X
Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
